Susquehanna International Group
ASMB icon

Susquehanna International Group’s Assembly Biosciences ASMB Stock Holding History

Susquehanna International Group’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,533
Closed -$43K – 12933
2021
Q4 		$43K Sell
1,533
-600
-28% -$19.7K ﹤0.01% 12618
2021
Q3 		$89K Sell
2,133
-2,159
-50% -$90.5K ﹤0.01% 12123
2021
Q2 		$200K Sell
4,292
-958
-18% -$47.5K ﹤0.01% 11598
2021
Q1 		$290K Buy
+5,250
New +$348K ﹤0.01% 10673
2020
Q2 		– Sell
-3,242
Closed -$577K – 10085
2020
Q1 		$577K Buy
+3,242
New +$695K ﹤0.01% 6604
2019
Q2 		– Sell
-1,933
Closed -$457K – 10184
2019
Q1 		$457K Buy
+1,933
New +$489K ﹤0.01% 6450
2018
Q4 		– Sell
-1,433
Closed -$639K – 8891
2018
Q3 		$639K Sell
1,433
-625
-30% -$293K ﹤0.01% 6087
2018
Q2 		$968K Sell
2,058
-4,175
-67% -$2.21M ﹤0.01% 5420
2018
Q1 		$3.68M Buy
6,233
+525
+9% +$326K ﹤0.01% 2940
2017
Q4 		$3.1M Buy
5,708
+2,983
+109% +$1.35M ﹤0.01% 3185
2017
Q3 		$1.14M Buy
+2,725
New +$835K ﹤0.01% 5036
2017
Q2 		– Sell
-4,433
Closed -$1.36M – 9156
2017
Q1 		$1.36M Buy
4,433
+350
+9% +$85.9K ﹤0.01% 4488
2016
Q4 		$595K Buy
+4,083
New +$607K ﹤0.01% 6618
2014
Q3 		– Sell
-308
Closed -$24K – 9392
2014
Q2 		$24K Sell
308
-12
-4% -$851 ﹤0.01% 9675
2014
Q1 		$25K Buy
320
+102
+47% +$15.9K ﹤0.01% 8771
2013
Q4 		$50K Sell
218
-369
-63% -$67.2K ﹤0.01% 8796
2013
Q3 		$102K Buy
587
+350
+148% +$53.6K ﹤0.01% 8077
2013
Q2 		$34K Buy
+237
New +$37.1K ﹤0.01% 8037

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Susquehanna International Group's ASMB Position: Q1 2026 in Review

Susquehanna International Group reduced its Assembly Biosciences (ASMB) stake by 59% in Q1 2026, selling an estimated $1.35M and leaving 32,949 shares worth $914K. The position accounts for ﹤0.01% of the portfolio, ranked #8113.

Susquehanna International Group first reported a position in ASMB in Q3 2013 and has held it in 37 quarters since. The position peaked at $4.5M in Q2 2018. 75 funds tracked by Wall St. Rank hold ASMB as of Q1 2026.

  • Susquehanna International Group held 32,949 shares of Assembly Biosciences worth $914K as of Q1 2026.
  • Susquehanna International Group sold 47,445 Assembly Biosciences shares in Q1 2026, an estimated $1.35M.
  • Assembly Biosciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8113 holding.
  • Susquehanna International Group first reported a position in Assembly Biosciences in Q3 2013 and has held it in 37 quarters since.
  • Susquehanna International Group's Assembly Biosciences position peaked at $4.5M in Q2 2018.
  • 75 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.